Relevance of the Urine Bacterial Culture Performed Before TransUrethral Resection of the Bladder for Post-operative Febrile Urinary Tract Infections Prevention: a Non-inferiority Randomized Controlled Trial
Ориентир для пациента и семьи
Простыми словами
Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.
- Что изучают
- В протоколе указаны: Urine bacterial Culture (UC), No intervention before TURB surgery.
- Кому может быть актуально
- Состояния в реестре: Bladder Cancer, Transurethral Resection of the Bladder, Urinary Tract Infection Bacterial. Базовые параметры: от 18 лет · Все.
- Что важно проверить
- Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
- Где проводится
- Франция
- Следующий шаг
- Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Не всё понятно в терминах? Прочитайте наш гид для пациентов →
Обзор
The main objective of the study is to demonstrate that not performing a systematic UC before the TURB procedure is non-inferior to performing a systematic UC in terms of the incidence of febrile UTIs during the first 30 postoperative days
Подробное описание
Transurethral resection of the bladder (TURB) is a routinely performed surgery in urology (65,000/y in France). Its primary indication is the management of bladder cancer for diagnostic, prognostic, and therapeutic purposes. Currently, both French and European guidelines recommend screening for asymptomatic bacteriuria (ABU) using a urine culture (UC) before TURB. If the UC is positive, antibiotic treatment must be initiated 48 hours before surgery and continued for a maximum of 7 days after the procedure. Theoretically, the purpose of preoperative ABU screening before TURB is to reduce the rate of post-operative urinary tract infections (UTIs). However, there is currently a lack of high-level studies justifying this approach, despite its being a recommended practice. The literature estimates the rate of post-TURB UTIs to be between 2% and 3.7%. In a recent French multicentre retrospective study, the rate of postoperative febrile UTI was 2.3%. This study did not find a significant association between positive pre-operative UC and a post-operative febrile UTI. Moreover, these post-TURB infections are generally of moderate severity (Grade 2 of Clavien-Dindo classification) and do not progress to sepsis. The rate of severe infections is estimated between 0.3% and 0.74%, and no study has yet demonstrated the link between the presence of a positive preoperative UC and an increased risk of postoperative infection. The causality between preoperative UC and postoperative UTIs remains unestablished. According to the TOCUS study, approximately one-third of patients exhibit ABU before undergoing urological surgery, translating to approximately 20,000 patients annually in France. Despite the relatively low rate of post-TURB UTIs and their mild severity, guidelines mandate antibiotic treatment for these patients. Antibiotic resistance is now a daily concern for clinicians and countries alike. A prominent 2014 WHO report emphasized the consequences of antibiotic resistance, including its impact on morbidity, mortality, and societal costs. The risk of entering a post-antibiotic era by 2050 could become a reality if strong measures are not taken immediately. Therefore, we propose a non- inferiority randomized controlled trial to investigate the impact of not performing pre-operative UC before TURB on the incidence of post-TURB febrile UTIs.
Вмешательства
- Диагностический тест Urine bacterial Culture (UC)
Performing a systematic UC before the TURB surgery - Другое No intervention before TURB surgery
No Urine Culture before TURB Surgery
Первичные конечные точки
- Proportion of patients with post-TURB symptomatic febrile Urinary Tract Infection (UTI) [Срок оценки: During the 30 days following TURB surgery.]
Вторичные конечные точки (10)
- Proportion of patients with postponed TURB surgery [Срок оценки: Between the pre-operative consultation and date of TURB surgery, up to 60 days]
- Time to surgery (in days), defined by the number of days between the pre-operative consultation and the date of TURB surgery [Срок оценки: Between the pre-operative consultation and the date of TURB surgery, up to 60 days]
- The hospital length of stay [Срок оценки: Between TURB surgery and day 30 after TURB surgery]
- Proportion of patients with hospital readmission or postoperative complications [Срок оценки: Within 30 days following the TURB surgery]
- Proportion of patients with hospital readmission linked to the urinary surgical procedure [Срок оценки: Within 30 days following the TURB surgery]
- Proportion of patients with systemic UTI among patients with hospital readmission [Срок оценки: Within 30 days following the TURB surgery]
- Proportion of patients with pre-operative antibiotic prescription for preoperative colonization before the TURB surgery [Срок оценки: Between Visit 0 (pre-operative consultation) and Visit 1(TURB surgery)]
- Proportion of patients with post-operative antibiotic prescription [Срок оценки: Within 30 days following the TURB surgery]
- Time to post-TURB infection diagnosis [Срок оценки: Between the TURB surgery and the infection diagnosis date (truncated at day 30)]
- Overall survival time [Срок оценки: Between TURB surgery and the date of death (censored at day 30)]
Критерии участия
Критерии включения
- Patient aged 18 or over
- Scheduled for TURB surgery for a suspected or confirmed diagnosis of bladder tumor
- Affiliated person or beneficiary of a social security scheme
- Written informed consent obtained from the participant
Критерии исключения
- Patient with active UTI
- Planned combined surgery
- Patient previously included in this research protocol
- People benefiting from enhanced protection, namely minors, people deprived of their liberty by judicial or administrative decision, people staying in a health or social institution, adults under legal protection
- Pregnant or breastfeeding women, women of childbearing age who do not have effective contraception (Combined (estrogen and progestogen containing) hormonal contraception associated with inhibition of ovulation : oral, intravaginal, transdermal; Progestogen-only hormonal contraception associated with inhibition of ovulation : oral, injectable, implantable; Intrauterine device; Intrauterine hormone-releasing system; Bilateral tubal occlusion) or permanent sterilization methods ( hysterectomy, bilateral salpingectomy, bilateral oophorectomy).
Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.
Здоровые добровольцы: Нет
Дизайн исследования
- Распределение
- Рандомизированное
- Модель
- Параллельные группы
- Маскирование
- Открытое
- Основная цель
- Другое
Центры проведения
Франция · 15 центров
- Centre Hospitalier Universitaire d'Angers — Angers
- Centre Hospitalier Universitaire de Grenoble Alpes — Grenoble
- Centre Hospitalier de Chartres - Hôpital Louis Pasteur — Le Coudray
- Centre Hospitalier Universitaire de Lille — Lille
- Hospices Civils de Lyon — Lyon
- Assistance Publique - Hôpitaux de Marseille - Hôpital Nord — Marseille
- Centre Hospitalier Intercommunal de Mont de Marsan et du Pays des Sources — Mont-de-Marsan
- Centre Hospitalier Universitaire de Nantes - Hotel Dieu — Nantes
- … и ещё 7 центров
Идентификаторы
NCT: NCT07463963 · 2025-A01451-48